The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.
AMSBIO (Oxford, UK) has launched a new range of deubiquitinating (DUB) enzyme assay kits supplied in a convenient and easy-to-use 96-well assay format. With minimal setup required and no need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results